Mitobridge
Biotechnology, 1030 Ave, Cambridge, Massachusetts, 02138, United States, 11-50 Employees
Phone Number: 16*********
Who is MITOBRIDGE
Our mission is to identify novel therapeutics that target cellular pathways leading to enhanced mitochondrial function and improved human health. Mitobridge is a biotechnology company dis...
Read More
-
Headquarters: 1030 Massachusetts Ave, Cambridge, Massachusetts, 02138, United States
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 621111 |
Show More
Does something look wrong? Fix it. | View contact records from MITOBRIDGE
Mitobridge Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Mitobridge
Answer: Mitobridge's headquarters are located at 1030 Ave, Cambridge, Massachusetts, 02138, United States
Answer: Mitobridge's phone number is 16*********
Answer: Mitobridge's official website is https://mitobridge.com
Answer: Mitobridge's revenue is $25 Million to $50 Million
Answer: Mitobridge's SIC: 2834
Answer: Mitobridge's NAICS: 621111
Answer: Mitobridge has 11-50 employees
Answer: Mitobridge is in Biotechnology
Answer: Mitobridge contact info: Phone number: 16********* Website: https://mitobridge.com
Answer: Our mission is to identify novel therapeutics that target cellular pathways leading to enhanced mitochondrial function and improved human health. Mitobridge is a biotechnology company discovering and developing new small molecule modulators that boost mitochondrial functions. We are capitalizing on the latest biological findings that have revealed new insights into the complex mechanisms that regulate mitochondrial activities. The mitochondrion is a potential untapped target for drug discovery. Given the central role that they play in cellular functions, Mitobridge believes that pharmacological manipulation of this organelle will enable the establishment of novel medicines that address human diseases in new ways. Mitobridge is utilizing advanced technologies to develop a unique drug discovery platform for the identification and evaluation of compounds that effectively improve mitochondrial functions or correct mitochondrial dysfunctions. Our strategy is centered on the evolving scientific understanding of mitochondrial biology. Using a multi-faceted approach to discover small molecule compounds that address mitochondrial dysfunction, we are producing drug candidates that have the potential to treat a wide range of medical conditions, for example, metabolic, and musculoskeletal diseases, some of which may be genetic disorders. As a result, Mitobridges therapeutic candidates have the potential to address both rare diseases and conditions that affect large patient populations. Mitobridge has assembled an experienced management and scientific team with a proven track record for discovering ground-breaking drugs and building successful biotech companies. The Company was founded by world-renowned leaders in mitochondrial biology and metabolism. Mitobridge is funded by leading financial and corporate investors.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month